Glenn D. Steele's Insider Trades & SAST Disclosures

Glenn D. Steele's most recent trade in PTC Therapeutics Inc was a trade of 8,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 3, 2025.

Share

Note

This is a custom search result for pattern Glenn D. Steele.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Show

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
PTC Therapeutics Inc	Glenn D. Steele	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2025	8,800	8,800	-		-	Stock Option (Right to Buy)
PTC Therapeutics Inc	Glenn D. Steele	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2025	4,000	18,500 (0%)	0%		0	Common Stock
PTC Therapeutics Inc	Glenn D. Steele	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2024	10,000	10,000	-		-	Stock Option (Right to Buy)
PTC Therapeutics Inc	D. Glenn Steele	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2024	4,000	14,500 (0%)	0%		0	Common Stock
PTC Therapeutics Inc	Glenn D. Steele	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2023	10,000	10,000	-		-	Stock Option (Right to Buy)
PTC Therapeutics Inc	Glenn D. Steele	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2023	4,000	10,500 (0%)	0%		0	Common Stock
PTC Therapeutics Inc	Glenn D. Steele	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jan 2022	12,000	12,000	-		-	Stock Option (Right To Buy)
PTC Therapeutics Inc	Glenn D. Steele	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jan 2022	3,200	6,500 (0%)	0%		0	Common Stock
PTC Therapeutics Inc	Glenn D. Steele	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jan 2021	10,000	10,000	-		-	Stock Option (Right To Buy)
PTC Therapeutics Inc	Glenn D. Steele	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jan 2021	1,650	3,300 (0%)	0%		0	Common Stock

Showing 1 to 10 of 10 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades